STATE OF THE ART & FUTURE DIRECTIONS
We are delighted to invite you all to join us in the Year in Cardiology 2021! Promising you to deliver the richest and the most comprehensive educational program yet in the region, with very unique experts gathering showcasing the latest in the cardiology field and a whole lot more!
Emirates Cardiac Society
Tranlational Medicine Academy
In collaboration with
Angina Awareness Initiative
Professor of Cardiology
St George’s Hospitals NHS Trust
University of London, United Kingdom
ABDULLAH SHEHAB
Professor of Cardiovascular Medicine
Editor in Chief NEMJ, UAE
Vice President of Gulf Intervention Society
Professor of Cardiovascular Medicine, Editor chief New Emirates Medical Journal, Vice President Gulf Intervention Society
Consultant Cardiologist & Interventional Cardiac Electrophysiologist, Bahrain Defence Force Hospital - Cardiac Centre, Bahrain
Senior Consultant Cardiologist, Fujairah Hospital, UAE
Director of the Monash Warwick Alliance Academic Vice-PresidentMonash and Warwick Universities, UK
Professor and Head of Laboratory of Applied Research on Cardiovascular System, Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland
Professor of Cardiology and Consultant Cardiologist at St. George’s Hospitals NHS Trust University of London, UK
Consultant Cardiologist, Heart and Vascular Institute at Cleveland Clinic Abu Dhabi, UAE
Senior Consultant of Public Health & Cardiovascular Disease (Heart Failure), Ministry of Health, Oman
Cardiac Electrophysiologist Established Tawam EP and Pacing Laboratory in Alain City, Leading One of the Highest Volume Centers in EP in UAE
Consultant Cardiologist, Kalba Hospital, Ministry of Health, Sharjah, UAE
Consultant Interventional Cardiologist, Head of Adult Cardiology, Kids Heart, UAE
Professor of Innovative Clinical TrialsUniversity Medical Center Göttingen in Germany
CME APPLIED
1
Review the burden of cardiovascular disease as one of the leading causes of disability and mortality worldwide
2
Understand the latest evidence about heart failure, coronary artery disease, angina, dyslipidemia, diabetes and cardiovascular prevention
3
Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts
4
Develop a comprehensive understanding of best practices for the screening, diagnosis and management with a multidisciplinary approach
5
Discuss the specific role of SGLT2 inhibition in the treatment algorithm
6
Provide the most up-to-date information in the latest scientific guidelines and give a comprehensive update of novel insights relevant both to the prevention and treatment of cardiovascular diseases
Our
Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as non-prescription medicines.
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
PCO in Charge: ICOM
Damac Business tower 1
Business Bay - Dubai, UAE
Land Line: +971 44307892
Reem Abdelwahed
reem.abdelwahed@icomgroup.org